Founded in 2017, NeuroLeap operates in Health Tech industry. Originally focused on using advanced neuroscience for mental health improvement, it has since broadened its scope to offer customisable bra...
Funding stage:
Angel Round
Last funding:
08/10/2019
Investors
Employee count:
8
Last 90d
8
Last 90d
Web traffic:
1.41K
1.41K
Last 30d
Last 30d
NeuroLeap: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders5
Latest Filing Date30 March 2023- Funding Events7
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of NeuroLeap
As of 31 March 2023, NeuroLeap's equity is held by 5 shareholders, with the top three being Kumaar Bagrodia, Rituu Kumar Bagrodia, and Rajashree Birla.
Kumaar Bagrodia holds the largest stake in NeuroLeap at 49.2% as of 31 March 2023.
As of 31 March 2023, founders collectively hold 49.2% equity in NeuroLeap.
As of 31 March 2023, investors collectively hold 1.6% equity in NeuroLeap.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links